Abstract | BACKGROUND: METHODS: A total of 99 patients (average age: 30 years (18-45 years old)) with cervical HSIL and high-risk Human Papilloma Virus (hr- HPV) infections and who had received ALA- PDT were enrolled in this retrospective study. Before ALA- PDT, cervical exfoliated cells from all patients were obtained for HPV genotyping, liquid-based cytology test (LBC) and PAX1 methylation (PAX1m) test. Then, 6 months after ALA- PDT, HPV genotyping, LBC and colposcopy-directed biopsy were conducted. During subsequent follow-up, HPV genotyping and LBC were performed, and colposcopy-directed biopsy was conducted if hr-HPV was positive and/or LBC result was abnormal. RESULTS: At 6 months after treatment, total HPV clearance and lesions complete remission (CR) rates were 64.6% (64/99) and 88.9% (88/99), while at 1-year of follow-up, they were 81.3% (65/80) and 92.5% (74/80), respectively. At 1-year follow-up, HPV clearance rate was higher, relative to 6 months after ALA- PDT (p <0.05). At 6 months after treatment, HPV clearance and CR rates in the PAX1 hypermethylation (PAX1hm) group were 36.8% and 73.7%, which were lower compared to the rates for PAX1 hypomethylation (PAX1lm) group (71.3%, 92.5%) (p <0.05). Moreover, of the 11 patients with cervical canal lesions, 3 (3/7, 42.9%) patients had cervical canal HSIL persistence and the other 4 cervical canal HSIL and all of the 4 cervical canal LSIL had complete remission. CONCLUSIONS: ALA- PDT is an effective, safe treatment approach for patients with cervical HSIL and hr- HPV infections. Patients with PAX1lm showed better therapeutic outcomes than patients with PAX1hm or cervical canal HSIL.
|
Authors | Yujie Tang, Yuehui Su, Yue Xu, Yingcui Zhang, Yan Shen, Lihong Qin, Luoman Zhang, Lili Cao, Yingying Zhou, Ting Zhang, Mengzhen Zhang |
Journal | Photodiagnosis and photodynamic therapy
(Photodiagnosis Photodyn Ther)
Vol. 39
Pg. 102884
(Sep 2022)
ISSN: 1873-1597 [Electronic] Netherlands |
PMID | 35500740
(Publication Type: Journal Article)
|
Copyright | Copyright © 2022. Published by Elsevier B.V. |
Chemical References |
|
Topics |
- Adolescent
- Adult
- Aminolevulinic Acid
(therapeutic use)
- Carcinoma, Squamous Cell
(drug therapy)
- Female
- Humans
- Middle Aged
- Papillomavirus Infections
(drug therapy, pathology)
- Photochemotherapy
(methods)
- Retrospective Studies
- Squamous Intraepithelial Lesions
- Uterine Cervical Neoplasms
(drug therapy)
- Young Adult
|